FDA approves eye drops that fix near vision without glasses
17 days ago
- #eye health
- #FDA approval
- #presbyopia
- FDA approves first aceclidine-based eye drop, VIZZ, for treating presbyopia in adults.
- VIZZ offers improved near vision for up to 10 hours without affecting distance vision.
- The eye drop works by creating a 'pinhole effect' by gently shrinking the pupil.
- Unlike older treatments, VIZZ avoids side effects like blurred distance vision or myopic shift.
- Expected to be available in Q4 2025, VIZZ is the first and only FDA-approved aceclidine-based treatment for presbyopia.
- Clinical trials showed VIZZ was well-tolerated with no serious adverse events.
- Presbyopia affects over 128 million adults in the US, typically starting after age 45.
- VIZZ is considered a best-in-class treatment due to its pupil-selective, ciliary-sparing mechanism.